Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Pub. Ch. 295
Email me when HB 1239 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1239. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Ask about HB 1239
3 free questions a day, no accountVote
92 yes
1 no
Passed H., as am., Ayes 92, Nays 1, PNV 0 · Apr 7, 2025
History
- Pub. Ch. 295
- Effective date(s) 07/01/2025
- Signed by Governor.
- Transmitted to Governor for his action.
- Signed by Senate Speaker
- Signed by H. Speaker
- Enrolled; ready for sig. of H. Speaker.
- Sponsor(s) Added.
- Senate substituted House Bill for companion Senate Bill.
- Received from House, Passed on First Consideration
- Passed Senate, Ayes 27, Nays 4
- Passed H., as am., Ayes 92, Nays 1, PNV 0
The 12 most recent of 27 recorded actions.
Sponsors
- Helton-Haynes · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1239 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1239 freeOr ask your AI assistant about HB 1239 directly:
Add to Claude, ChatGPT or Cursor